<DOC>
	<DOC>NCT02209545</DOC>
	<brief_summary>The aim of this research work is to assess the impact of a single preoperative dose of buccal misoprostol in reducing blood loss during abdominal fibroid surgery.</brief_summary>
	<brief_title>Misoprostol for Reduction of Blood Loss During Fibroid Surgery</brief_title>
	<detailed_description>This is a trial of women undergoing fibroid surgery at a university-affiliated tertiary care center. Eligible participants will be randomized to receive preoperative 400ucg buccal (under the tongue) misoprostol or placebo on the basis of total fibroid volume, location, parity. Intra-operative blood loss will be compared between groups.</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging (pelvic ultrasound or MRI) within in last 12 months Age ≥ 18 years and ≤ 50 years Preoperative hemoglobin &gt;8 g/dl Willing to have buccal administration of misoprostol or a placebo at least one hour preprocedure. Ability to understand and the willingness to sign a written informed consent. Admissible medical/surgical history Can be previously treated with DepoLupron, DepoProvera, or Oral Contraceptive pills Intraoperative use of vasopressin and uterine tourniquet is permissible Can have had prior Cesarean delivery Patients who have had a prior abdominal myomectomy Postmenopausal women Patients with known bleeding/clotting disorders Patients with a history of gynecologic malignancy History of allergic reactions attributed to compounds of similar chemical or biologic composition to misoprostol Any cases converted to abdominal hysterectomy or other additional elective surgical procedures performed at time of abdominal myomectomy will be excluded from data analysis Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>fibroids, leiomyomata, blood loss, misoprostol</keyword>
</DOC>